NEW DELHI: The Ayush ministry on Friday said it has launched a massive nationwide campaign to distribute its proven poly herbal ayurvedic drug AYUSH 64 and Sidha medicine Kabasura Kudineer for the benefit of Covid patients in home isolation.
The efficacy of these drugs has been proved through robust multi-centre clinical trials, the ministry said in its statement.
AYUSH-64 is recommended in National Clinical Management Protocol based on ayurveda and yoga which is vetted by National Task Force on Covid Management of ICMR and Guidelines for Ayurveda Practitioners for Covid-19 patients in home isolation.
Kabasura Kudineer is included in Guidelines for Siddha Practitioners for Covid 19 issued by the ministry of Ayush, the statement stated.
Covid-19 vaccination: What explains the mixed response in India?
India Today TV Consulting Editor Rajdeep Sardesai spoke to AIIMS Director Randeep Guleria, who is also a member of the national task force on Covid-19 management, to understand why there is such a mixed response to the coronavirus vaccination drive.
advertisement
UPDATED: January 19, 2021 00:44 IST
AIIMS Director Dr Randeep Guleria receiving the Covid-19 vaccine in Delhi in the presence of Union Health Minister Dr Harsh Vardhan on January 16 (Photo Credits: PTI)
In some states like Telangana and Odisha, the success of Covid-19 vaccination is as high as 80 per cent, while it s a mere 20 per cent in Tamil Nadu and Punjab.